Yevgeniya Ioffe

Yevgeniya Ioffe, MD is a Professor in the Department of Gynecology and Obstetrics at Loma Linda University School of Medicine. Her research focuses on gynecologic oncology, particularly ovarian and cervical cancers, with an emphasis on treatment protocols, genetic testing disparities, and improving clinical outcomes through multidisciplinary approaches. She leads multiple clinical trials evaluating therapies like PARP inhibitors and dexamethasone regimens, and her work spans molecular mechanisms (e.g., miRNA regulation) and translational medicine.

• Roles: Principal Investigator (PI) on SWOG and institutional grants, leading studies on chemoradiation efficacy and cancer stem cell models.
• Education: Medical degree and academic training in gynecologic oncology (details not explicitly stated in text).

Research interests include epithelial-mesenchymal transition in cancer progression, cultural adaptations in healthcare (e.g., Chichewa translation of cancer questionnaires), and optimizing care for Latinx communities. Her recent articles address platinum resistance in ovarian cancer, treatment-induced side effects (e.g., Sweet Syndrome), and surgical innovations like REBOA for placenta accreta.

Grants include multi-year projects on anti-CTLA-4/PD-1 combination therapies, ovarian cancer xenograft models, and the impact of air pollution on gynecologic malignancies. She collaborates with organizations like the Southwest Oncology Group (SWOG) and NRG Oncology.

Labs/teams: Involved with LLU Cancer Center biospecimen lab and multidisciplinary teams managing placenta accreta and cervical cancer patients.